Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 26, 2026 16:05 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

SOUTH SAN FRANCISCO, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver...
May 26, 2026 10:46 ET | Source: Research and Markets

Asia Drug Development Beyond China Strategic Intelligence Report 2026: Pharma R&D and Deal Trends in South Korea, Japan, and India

Dublin, May 26, 2026 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: Asia Beyond China: Pharma R&D and Deal Trends in South Korea, Japan, and India" report has been added to ...
May 26, 2026 10:30 ET | Source: Research and Markets

Pharma 4.0 Market Research and Growth Analysis Report 2026-2033

Dublin, May 26, 2026 (GLOBE NEWSWIRE) -- The "Pharma 4.0 Market Size, Share & Trends Analysis Report by Type, Technology, Application, End Use, Region, and Growth Forecasts, 2026-2033" has been...
May 22, 2026 07:00 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases

– Phase 2 study in cholestatic liver diseases, focused on PBC and PSC, anticipated to initiate in Q1 2027 –– Builds on completed Phase 1a study and ongoing development in HDV – SOUTH SAN FRANCISCO,...
May 21, 2026 07:07 ET | Source: Research and Markets

Emerging Drugs Global Market Research Report 2026: Innovations Center on Biologics, ADCs, Cell and Gene Therapies, and RNA-based Medicines, Addressing Unmet Medical Needs in Oncology, Rare Diseases

Dublin, May 21, 2026 (GLOBE NEWSWIRE) -- The "Emerging Drugs: Global Markets" report has been added to ResearchAndMarkets.com's offering.The report provides an overview of the global emerging drugs...
May 21, 2026 03:30 ET | Source: Orion Oyj

Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting

ORION CORPORATION PRESS RELEASE 21 MAY 2026 at 10:30 EEST Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting First...
May 21, 2026 03:30 ET | Source: Orion Oyj

Orion Pharma julkistaa ensimmäisiä kliinisiä tuloksia Faasi 1/2 TEADES-tutkimuksesta ODM-212-molekyylillä (TEAD-estäjä) 2026 ASCO®-vuosikokouksessa

ORION OYJ LEHDISTÖTIEDOTE 21.5.2026 KLO 10.30 Orion Pharma julkistaa ensimmäisiä kliinisiä tuloksia Faasi 1/2 TEADES-tutkimuksesta ODM-212-molekyylillä (TEAD-estäjä) 2026...
May 20, 2026 10:25 ET | Source: Research and Markets

Medical Foods Market Size, Share & Trends Analysis Report 2025-2026 & 2033 by Route of Administration, Product, Application, Sales Channel, Module, Region

Dublin, May 20, 2026 (GLOBE NEWSWIRE) -- The "Medical Foods Market Size, Share & Trends Analysis Report by Route of Administration, Product, Application, Sales Channel, Module, Region, and...
May 19, 2026 12:37 ET | Source: Sanofi Winthrop Industrie

Sanofi: Information concerning the total number of voting rights and shares - April 2026

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
May 19, 2026 12:37 ET | Source: Sanofi Winthrop Industrie

Sanofi: Informations relatives au nombre de droits de vote et d'actions - Avril 2026

Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...